Biotech Spinout Case Study: Kinomica – From Seed To Oversubscribed £3.9m Series A.Gemma Cann2024-11-28T14:08:54+00:00November 19th, 2021|Accelerator, Article|
The Epicentre Of The Drug Industry: How CROs Became The Backbone Of BiopharmaGemma Cann2024-11-28T14:09:23+00:00November 19th, 2021|Article|
Two Years Later: We Catch Up With Alex Birks, CEO Of Med-Tech Start-Up Suji BFRGemma Cann2024-11-28T14:19:34+00:00November 19th, 2021|Accelerator, Article|
Why The Pioneer Group Accelerator Programme Wants To Help You Get it WrongGemma Cann2024-11-28T14:10:12+00:00November 19th, 2021|Accelerator, Article|
Key To The Vault – Part 2. How To Secure InvestmentGemma Cann2024-11-28T14:10:29+00:00November 19th, 2021|Article, Investment|
Key To The Vault – Part 1. How To Secure InvestmentGemma Cann2024-11-28T14:10:48+00:00November 19th, 2021|Article, Investment|
Inspiring The Next Generation Of Women In ScienceGemma Cann2024-11-28T14:11:08+00:00November 16th, 2021|Article|
Almac Discovery Expands Disease Focus Into Respiratory DiseaseGemma Cann2024-11-26T12:21:23+00:00July 20th, 2021|Article, Edinburgh Technopole|
Is Now A Good Time To Start A Business? Pro Con ListGemma Cann2024-11-28T14:11:42+00:00August 11th, 2020|Accelerator, Article, Investment|
The Rights And Wrongs Of Life Science Entrepreneurship. We Want To Help You Get It WrongGemma Cann2024-11-28T14:12:24+00:00May 2nd, 2019|Accelerator, Article|
